- Home
- ONC
ONC
BeiGene Ltd. American Depositary Shares
as 04-18-2025 12:41pm EST
| Founded: | 2010 | Country: | Cayman Islands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 19.3B | IPO Year: | N/A |
| Target Price: | $324.33 | AVG Volume (30 days): | 617.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $126.97 - $287.88 | Next Earning Date: | 05-07-2025 |
| Revenue: | $3,810,241,000 | Revenue Growth: | 54.97% |
| Revenue Growth (this year): | 856.26% | Revenue Growth (next year): | 19.78% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
BeiGene to Announce First Quarter 2025 Financial Results on May 7
MT Newswires
12 days ago
RBC Initiates BeiGene at Outperform With $312 Price Target
Simply Wall St.
14 days ago
BeiGene (NasdaqGS:ONC) Gains 32% In A Quarter Amid Positive EMA Opinion On TEVIMBRA
Clinical Trials Arena
16 days ago
BeiGene halts ociperlimab amid poor Phase III trial predictions
MT Newswires
16 days ago
BeiGene to Discontinue Potential Lung Cancer Treatment Study
Business Wire
16 days ago
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
MT Newswires
19 days ago
BeiGene Says EMA Panel Recommends Approval of Tevimbra for Lung Cancer
Simply Wall St.
19 days ago
Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.